| Parameter estimate | p value | Hazard ratio | 95% CI |
---|---|---|---|---|
AT | ||||
 Age | 0.020 | 0.001 | 1.020 | 1.008–1.033 |
 Treatment | − 1.075 | < 0.001 | 0.341 | 0.254–0.459 |
 Stage | 0.144 | < 0.001 | 1.155 | 1.072–1.245 |
GCM3 | ||||
 Age | 0.019 | 0.003 | 1.019 | 1.006–1.032 |
 Treatment | − 1.024 | < 0.001 | 0.359 | 0.266–0.485 |
 Stage | 0.142 | < 0.001 | 1.153 | 1.068–1.245 |
 Kurtosis | 0.632 | 0.002 | 1.882 | 1.260–2.809 |
 Skewness | − 0.789 | 0.044 | 0.454 | 0.211–0.980 |
KM2 | ||||
 Age | 0.020 | 0.001 | 1.020 | 1.008–1.033 |
 Treatment | − 1.075 | < 0.001 | 0.341 | 0.254–0.459 |
 Stage | 0.144 | < 0.001 | 1.155 | 1.072–1.245 |
WT | ||||
 Age | 0.018 | 0.004 | 1.018 | 1.006–1.031 |
 Treatment | − 1.063 | < 0.001 | 0.345 | 0.257–0.464 |
 Stage | 0.140 | < 0.001 | 1.150 | 1.065–1.242 |
 GLNU | 0.017 | 0.006 | 1.017 | 1.005–1.029 |
 Skewness | 0.674 | 0.030 | 1.962 | 1.067–3.607 |